{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(10)"],"submitter":["Giallongo C"],"pubmed_abstract":["Inflammation represents a key feature and hallmark of tumor microenvironment playing a major role in the interaction with mesenchymal stromal cells (MSC) in cancer progression. The aim of the present study was to investigate the crosstalk between MSCs and myeloma cells (MM) in the pro-inflammatory microenvironment promoting immune evasion and tumor growth. MSC were collected from patients with diagnosis of MGUS (n = 10), smoldering myeloma (n = 7), multiple myeloma at diagnosis (n = 16), relapse (n = 5) or refractory (n = 3), and from age-matched healthy controls (HC, n = 10) and cultured with peripheral blood mononucleated cells (PBMC) from healthy volunteer donors. Similarly to MM, we showed that MSC from smoldering multiple myeloma (SMM) patients activated neutrophils and conferred an i"],"journal":["Cell death & disease"],"pagination":["704"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6754430"],"repository":["biostudies-literature"],"pubmed_title":["TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma."],"pmcid":["PMC6754430"],"pubmed_authors":["Di Raimondo F","Camiolo G","Conticello C","Anfuso CD","Li Volti G","Giallongo C","Barbato A","Palumbo GA","Romano A","Puglisi F","Lazzarino G","Tibullo D","Parrinello NL","Lupo G"],"additional_accession":[]},"is_claimable":false,"name":"TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.","description":"Inflammation represents a key feature and hallmark of tumor microenvironment playing a major role in the interaction with mesenchymal stromal cells (MSC) in cancer progression. The aim of the present study was to investigate the crosstalk between MSCs and myeloma cells (MM) in the pro-inflammatory microenvironment promoting immune evasion and tumor growth. MSC were collected from patients with diagnosis of MGUS (n = 10), smoldering myeloma (n = 7), multiple myeloma at diagnosis (n = 16), relapse (n = 5) or refractory (n = 3), and from age-matched healthy controls (HC, n = 10) and cultured with peripheral blood mononucleated cells (PBMC) from healthy volunteer donors. Similarly to MM, we showed that MSC from smoldering multiple myeloma (SMM) patients activated neutrophils and conferred an i","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Sep","modification":"2025-04-04T22:11:41.222Z","creation":"2019-10-11T07:08:52Z"},"accession":"S-EPMC6754430","cross_references":{"pubmed":["31541083"],"doi":["10.1038/s41419-019-1959-5"]}}